Vimarsana
Biggest News Aggregation in the World

Page 3 - Stemcell United News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stemcell United. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stemcell United Today - Breaking & Trending Today

Starpharma's [ASX:SPL] Viraleze Nasal Spray Receives Approval in Malaysia - Vimarsana News

Starpharma's [ASX:SPL] Viraleze Nasal Spray Receives Approval in Malaysia

Biotech Starpharma has received regulatory approval for its Viraleze product to be used in Malaysia, adding the product to a wider market base that now spans 35 countries as it looks into further COVID-19 studies in the UK.

Homeco Daily Needs [ASX:HDN] REIT Evaluates Properties and Progress - Vimarsana News

Homeco Daily Needs [ASX:HDN] REIT Evaluates Properties and Progress

Australian real estate trust HomeCo Daily Needs has announced its June 2023 property valuations and talks progress on its accretive developments.

Lynch Group [ASX:LGL] Takes a Boost in Earnings for 2023 - Vimarsana News

Lynch Group [ASX:LGL] Takes a Boost in Earnings for 2023

Flower seller Lynch Group has upped its earnings guidance for the full year fiscal 2023, with expectations of revenue increasing 5% on a stronger performance in sales and returning of stores.

Aroa Biosurgery [ASX:ARX] Posts FY23 Results and Shares FY24 Outlook - Vimarsana News

Aroa Biosurgery [ASX:ARX] Posts FY23 Results and Shares FY24 Outlook

Biotech Aroa has released its audited results for the 2023 financial year, hitting targets and achieving its expectations. The company looks ahead with a positive perspective on FY24, with the group providing new guidance today.

Mesoblast [ASX:MSB] Trims Losses US$2.7 Million and Shares Rise - Vimarsana News

Mesoblast [ASX:MSB] Trims Losses US$2.7 Million and Shares Rise

Biotech company Mesoblast has released its Q3 financial report, saying that it cut losses after tax to US$18.6 million from US$21.3 million a year ago. Shares rose more than 4% during the group’s quarter improvement.